Patents-Review.com
🔗 Permalink
Assignee profile:

ADURO BIOTECH, INC.

City:

BERKELEY, California

Country:

United States

Published Applications:

30

Last publication date:

2021-08-12

Patent Grants:

23

Last grant date:

2021-06-22

Top Inventors for applications by ADURO BIOTECH, INC.

These are the the leading inventors for applications assigned to ADURO BIOTECH, INC.:

Recent patent applications by ADURO BIOTECH, INC.

ADURO BIOTECH, INC. based in BERKELEY, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2021-08-12
US20210246122A1
Chemistry; metallurgy

Triazine Compounds and Uses Thereof

 #2 | 2020-09-10
US20200282049A1
Human necessities

COMPOSITIONS AND METHODS FOR ACTIVATING "STIMULATOR OF INTERFERON GENE"-DEPENDENT SIGNALLING

 #3 | 2020-06-11 ✅ Patent 11,040,053 granted on 2021-06-22
US20200179431A1
Human necessities

Compositions and methods for activating “stimulator of interferon gene”13 dependent signalling

 #4 | 2019-06-20 ✅ Patent 11,098,077 granted on 2021-08-24
US20190185511A1
Chemistry; metallurgy

Locked nucleic acid cyclic dinucleotide compounds and uses thereof

 #5 | 2019-04-25 ✅ Patent 10,738,056 granted on 2020-08-11
US20190119285A1
Chemistry; metallurgy

Pyrazolopyrimidinone compounds and uses thereof

 #6 | 2019-02-28 ✅ Patent 10,906,930 granted on 2021-02-02
US20190062365A1
Chemistry; metallurgy

Compositions and methods for activating “stimulator of interferon gene”-dependent signalling

 #7 | 2019-01-17
US20190015488A1
Human necessities

METHODS AND COMPOSITIONS USING LISTERIA FOR ENHANCING IMMUNOGENICITY BY PRIME BOOST

 #8 | 2018-12-27
US20180369268A1
Human necessities

METHODS FOR IDENTIFYING INHIBITORS OF "STIMULATOR OF INTERFERON GENE"- DEPENDENT INTERFERON PRODUCTION

 #9 | 2018-10-04
US20180280489A1
Human necessities

ENGINEERED LISTERIA AND METHODS OF USE THEREOF

 #10 | 2018-03-08 ✅ Patent 10,449,211 granted on 2019-10-22
US20180064745A1
Human necessities

Compositions and methods for activating “stimulator of interferon gene”—dependent signalling

 #11 | 2018-02-01 ✅ Patent 10,526,609 granted on 2020-01-07
US20180030457A1
Chemistry; metallurgy

Protein expression enhancer sequences and use thereof

 #12 | 2018-01-25
US20180021420A1
Human necessities

METHODS AND COMPOSITIONS FOR INDUCING AN IMMUNE RESPONSE TO EGFRVIII

 #13 | 2018-01-04
US20180000917A1
Human necessities

ENGINEERED LISTERIA AND METHODS OF USE THEREOF

 #14 | 2017-11-23 ✅ Patent 10,653,774 granted on 2020-05-19
US20170333552A1
Human necessities

Compositions and methods for activating “stimulator of interferon gene”-dependent signalling

 #15 | 2017-10-05 ✅ Patent 10,414,789 granted on 2019-09-17
US20170283454A1
Chemistry; metallurgy

Compositions comprising cyclic purine dinucleotides having defined stereochemistries and methods for their preparation and use

 #16 | 2017-08-03 ✅ Patent 10,189,873 granted on 2019-01-29
US20170218008A1
Chemistry; metallurgy

Compositions and methods for inhibiting “stimulator of interferon gene”-dependent signalling

 #17 | 2016-12-01 ✅ Patent 10,105,427 granted on 2018-10-23
US20160346369A1
Human necessities

Epidermal growth factor receptor variant III-mesothelin fusions and methods of using the same

 #18 | 2016-11-10 ✅ Patent 9,808,516 granted on 2017-11-07
US20160324945A1
Human necessities

Immunogenic fusion proteins for the treatment of cancer

 #19 | 2016-06-23 ✅ Patent 9,878,024 granted on 2018-01-30
US20160175415A1
Human necessities

Methods and compositions using for enhancing immunogenicity by prime boost

 #20 | 2016-03-17 ✅ Patent 9,775,891 granted on 2017-10-03
US20160074491A1
Human necessities

Methods and compositions for inducing an immune response to EGFRvIII

 #21 | 2015-05-07 ✅ Patent 9,198,960 granted on 2015-12-01
US20150125485A1
Human necessities

Methods and compositions using listeria for enhancing immunogenicity by prime boost

 #22 | 2015-02-26 ✅ Patent 9,724,408 granted on 2017-08-08
US20150056224A1
Human necessities

Compositions and methods for activating stimulator of interferon gene-dependent signalling

 #23 | 2015-01-08 ✅ Patent 9,770,467 granted on 2017-09-26
US20150010613A1
Human necessities

Compositions and methods for cancer immunotherapy

 #24 | 2014-11-20 ✅ Patent 9,549,944 granted on 2017-01-24
US20140341976A1
Human necessities

Compositions and methods for inhibiting “stimulator of interferon gene”—dependent signalling

 #25 | 2014-10-23 ✅ Patent 9,764,013 granted on 2017-09-19
US20140315314A1
Human necessities

Engineered and methods of use thereof

 #26 | 2014-07-24 ✅ Patent 9,695,212 granted on 2017-07-04
US20140205653A1
Chemistry; metallurgy

Compositions comprising cyclic purine dinucleotides having defined stereochemistries and methods for their preparation and use

 #27 | 2014-07-03 ✅ Patent 9,663,557 granted on 2017-05-30
US20140186387A1
Chemistry; metallurgy

Signal peptide fusion partners facilitating listerial expression of antigenic sequences and methods of preparation and use thereof

 #28 | 2014-05-08 ✅ Patent 9,511,129 granted on 2016-12-06
US20140127816A1
Chemistry; metallurgy

Facultatively attenuated bacterial species and methods of preparation and use thereof

 #29 | 2013-11-28 ✅ Patent 9,161,974 granted on 2015-10-20
US20130315950A1
Human necessities

Methods and compositions using listeria for adjuvant treatment of cancer

 #30 | 2011-08-18 ✅ Patent 8,287,883 granted on 2012-10-16
US20110201092A1
Human necessities

attenuated for entry into non-phagocytic cells, vaccines comprising the and methods of use thereof

Also check out ADURO BIOTECH, INC.'s (Berkeley, United States) applicant profile with 18 patent applications submitted.

AssigneeID:

70170 ⎘